Folic acid and neural tube defects

Spinal Cord

Volumn 34, Issue 8, 1996, Pages 460-465

  Minns, R A ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Folic acid; Myelomeningocele; Neural tube defects; Paraplegia; Spina bifida

Indexed keywords

FOLIC ACID;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; EMBRYO DEVELOPMENT; FEMALE; HUMAN; HUMAN EXPERIMENT; MAJOR CLINICAL STUDY; MATERNAL CARE; MENINGOMYELOCELE; MULTICENTER STUDY; NEURAL TUBE DEFECT; PARAPLEGIA; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; SPINA BIFIDA;

EID: 0029789952     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sc.1996.79     Document Type: Short Survey

References (42)

1. Meuli M, Meuli-Simmen C, Hutchins GM et al. In utero surgery rescues neurological function at birth in sheep with spina bifida. Nature Med 1995; 1: 342-347.
2. Campbell LR, Dayton DH, Sohal GS. Neural tube defects: A review of human and animal studies on the etiology of neural tube defects. Teratology 1986; 34: 171-187.
3. Knoblock WH, Layer JM. Retinal detachment and encephalocele. J Pediatr Ophthalmol 1971; 8: 181.
4. Evrard P, Lyon G, Gadisseux JF. Le developpement prenatal du systeme nerveux et ses perturbations: mecanismes generaus. Progres en neonatologie vol. 4 Basel, NY: Karger, 1984; pp 63-69.
5. Copp AJ, Brook FA, Estibeiro JP, Shum ASW. The embryonic development of mammalian neural tube defects. Prog Neurobiol 1990; 35: 363-403.
6. Hibbard BM. The role of folic acid in pregnancy. J Obstet Gynaecol Brit Commwlth 1964; 71: 529-542.
7. Smithells RW, Shephard S, Schorah CJ et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980; i: 339-340.
8. Laurence KM, James N, Miller MH et al. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J 1981; 282: 1509-1511.
9. Laurence KM, James N, Miller MH et al. Increased risk of recurrence of pregnancies complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counselling. Br Med J 1980; 281 1592-1594.
10. Winship KA, Cahal DA, Weber JCP et al. Maternal drug histories and central nervous system anomalies. Arch Dis Child 1984; 59: 1052-1060.
11. Mulinare J, Cordero JF, Erickson D et al. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988; 260: 3141-3145.
12. Mills JL, Rhoads GG, Simpson JL et al. The national Institute of Child Health and Human Development Neural Tube Defect Study Group. The absence of a relation between the periconceptional use of vitamins and neural-tube defects. N Engl J Med 1989; 321: 430-435.
13. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989; 150: 613-618.
14. Milunsky A, Jick H, Jick SS et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989; 262: 2847-2852.
15. Vergel RG, Sanchez LR, Herdero BL et al. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 1990; 10: 149-152.
16. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-137.
17. Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-1835.
18. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Br Med J 1993; 306: 1645-1648.
19. 12 are independent risk factors for neural tube defects. Q J Med 1993; 86: 703-708.
20. Mills JL, McPartlin JM, Kirke PN et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995; 345: 149-151.
21. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM et al. Maternal hyperhomo-cysteinemia: a risk-factor for neural-tube defects? Metabolism 1994; 43: 1475-1480.
22. Adams MJ, Khoury MJ, Stevenson R et al. Midtrimester serum methylmalonic acid as a risk marker for neural tube defects. Society for Epidemiologic Research, 1993 Annual Meeting, Keystone, Colorado (abstr).
23. Goyette P, Sumner JS, Milos et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nature Genet 1994; 7: 195-200.
24. van der Put N, Steegers-Theunissen RPM, Frosst P et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1071.
25. Steegers-Theunissen RP, Boers GH, Trijbels FJ et al. Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med 1991; 324: 199-200.
26. 12 alters the frequency of neural tube defects in Axd mutant mice. J Nutr 1993; 123: 27-34.
27. Coelho CND, Weber JA, Klein NW et al. Whole rate embryos require methionine for neural tube closure when cultured on cow serum. J Nutr 1989; 119: 1716-1725.
28. Nau H. Valproic acid-induced neural tube defects. Ciba Found Symp (Netherlands) 1994; 181: 144-152.
29. Seller MJ. Vitamins, folic acid and the cause and prevention of neural tube defects. Ciba Found Symp (Netherlands) 1994; 181: 161-173.
30. Werler MM, Louik C, Shapiro S et al. Ovulation induction and risk of neural tube defects. Lancet 1994; 344: 445-446.
31. Wald NJ. Folic acid and neural tube defects: the current evidence and implications for prevention. In: Neural Tube Defects. Chichester: Wiley, 1994: pp 192-211. (CIBA Foundation Symposium 181).
32. Expert Advisory Group. Folic acid and the prevention of neural tube defects. Department of Health 1992. Published by Health Publications Unit, Heywood, Lancashire.
33. Sutcliffe M, Schorah CJ, Perry A et al. Prevention of neural tube defects Lancet 1993; 342: 1174.
34. Clark NAC, Fisk NM. Minimal compliance with the Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects. Br J Obstet Gynaecol 1994; 101: 709-710.
35. Ministry of Agriculture, Fisheries and Food. Household Food Consumption and Expenditure 1990 London: HMSO, 1991.
36. Wald NJ, Bower C. Folic acid, pernicious anaemia, and prevention of neural tube defects. Lancet 1994; 343: 307.
37. Wald NJ, Bower C. Folic acid and the prevention of neural tube defects. A population strategy is needed. Br Med J 1995; 310: 1019-1020.
38. Elwood JM, Elwood JH. Epidemiology of Anencephalus and Spina Bifida Oxford University Press: Oxford 1980.
39. Carstairs V, Cole S. Spina bifida and anencephaly in Scotland. Br Med J 1984; 289: 1182-1184.
40. Chan A, Robertson EF, Haan EA et al. Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis. Br Med J 1993; 307: 703-706.
41. Hunt GM. Open spina bifida: outcome for a complete cohort treated unselectively and followed into adulthood. Dev Med Child Neurol 1990; 32: 108-118.
42. Lorber J. Results of treatment of myelomeningocele. An analysis of 524 unselected cases with special reference to possible selection for treatment. Dev Med Child Neurol 1971; 13: 279-303.